Skip to main content
GENFIT logo

GENFIT — Investor Relations & Filings

Ticker · GNFT ISIN · FR0004163111 LEI · 969500XPWN2DMZQA5X73 PA Professional, scientific and technical activities
Open in API
Filings indexed 681 across all filing types
Latest filing 2021-01-08 AGM Information
Country FR France
Listing PA GNFT

About GENFIT

https://www.genfit.com

GENFIT is a biopharmaceutical company dedicated to developing therapeutic and diagnostic solutions for patients with rare and severe liver diseases characterized by high unmet medical needs. The company's primary focus is on Acute-on-Chronic Liver Failure (ACLF) and its associated conditions, such as acute decompensation (AD) and hepatic encephalopathy (HE). Leveraging a scientific heritage of over two decades, GENFIT is a pioneer in liver disease research and development, aiming to improve the lives of patients with these life-threatening conditions.

Recent filings

Filing Released Lang Actions
GENFIT informe ses actionnaires sur certaines modalités de l’Assemblée Générale Extraordinaire du 13 janvier 2021
AGM Information Classification · 98% confidence The document is a press release from GENFIT titled "GENFIT informe ses actionnaires sur certaines modalités de l'Assemblée Générale Extraordinaire du 13 janvier 2021" (GENFIT informs its shareholders about certain terms of the Extraordinary General Meeting of January 13, 2021). The content details procedural changes for shareholder participation (voting by proxy, written questions, broadcast access) due to COVID-19 regulations for an upcoming Extraordinary General Meeting (Assemblée Générale Extraordinaire). This type of communication, which provides specific information and procedural updates related to a shareholder meeting, aligns best with the definition of AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting (or related general meetings). Although it is an announcement, it is directly about the mechanics of the meeting itself, making AGM-R more specific than a general Report Publication Announcement (RPA) or Regulatory Filing (RNS).
2021-01-08 French
GENFIT Informs its Shareholders of Certain Procedures for the Extraordinary General Meeting of January 13, 2021
AGM Information Classification · 98% confidence The document is a press release from GENFIT informing shareholders about specific procedures for an upcoming Extraordinary General Meeting (EGM) scheduled for January 13, 2021. It details changes due to COVID-19 restrictions, specifically that the meeting will be held 'behind closed doors' and outlines procedures for proxy representation, submitting written questions, and accessing the broadcast. This content directly relates to the logistics, rules, and information provided to shareholders in preparation for a general meeting. This aligns perfectly with the definition of 'AGM Information' (AGM-R), even though the meeting is an 'Extraordinary' General Meeting, as it concerns the procedures and materials for a shareholder meeting.
2021-01-08 English
GENFIT : Participation à plusieurs événements financiers et organisation d’un KOL Event PBC
Report Publication Announcement Classification · 99% confidence The document is titled "COMMUNIQUÉ DE PRESSE" (Press Release) and announces the company's participation in several upcoming financial events and the organization of a KOL Event. It lists specific dates for conferences (Oddo Forum, Leerink Conference, etc.) and states that details for the KOL event will be communicated later, directing readers to the Investor Relations section of the website. This structure—announcing future participation in investor-facing events rather than releasing periodic financial results (ER/IR) or providing detailed audited data (10-K/AR)—is characteristic of an announcement intended to inform the investment community about upcoming engagement opportunities. Since it is an announcement about future events and not a formal regulatory report itself, and given the context of investor engagement, it fits best under the general category of investor communication or a regulatory filing that doesn't fit elsewhere. However, since it is a press release detailing future investor activities, it is most closely related to investor relations updates. Given the options, and noting that it is a general announcement about corporate activities aimed at investors, it is best classified as a Regulatory Filing (RNS) as a general announcement, or potentially related to Investor Presentation (IP) if it were the presentation itself, but here it is just an announcement of participation. Given the nature of a press release announcing participation in multiple external events, RNS (Regulatory Filings/General Announcement) is the most appropriate fallback, although it is highly focused on investor relations.
2021-01-06 French
GENFIT to Present at Upcoming Investor Conferences and Host a PBC KOL Event
Report Publication Announcement Classification · 99% confidence The document is a press release announcing that GENFIT will be presenting at several upcoming investor conferences and hosting a KOL event focused on Primary Biliary Cholangitis (PBC). It details the dates and nature of these events but does not contain a full financial report (like 10-K or IR), a transcript (CT), or a formal regulatory filing announcement about a specific report. This type of communication, which informs investors about participation in external events and future investor engagement activities, is best classified as general Investor Relations material. Since there is no specific category for 'Investor Event Announcement,' and it is not a presentation (IP) or a formal report announcement (RPA), the most appropriate general category for investor-focused, non-report-specific news is 'Regulatory Filings' (RNS) as a broad category for corporate announcements, or potentially 'Investor Presentation' (IP) if the conference presentations were considered the primary content, but since it's an announcement *about* attending, RNS is safer as a catch-all for non-standard IR news, or we must check if any other category fits better. Given the options, this is an announcement about future investor engagement, not a formal report or a specific transaction. It is not a proxy statement (PSI), dividend notice (DIV), or management change (MANG). It is most closely related to investor communication. Since it is an announcement of participation in external events, it functions as a general corporate update. 'RNS' is the fallback for miscellaneous regulatory/corporate announcements. However, if we consider the context of investor relations, it is an announcement of future investor engagement. Given the available codes, and that it is not a formal report, a presentation, or a specific transaction, 'RNS' (Regulatory Filings/Miscellaneous Announcement) is the most suitable fallback, although 'IP' might be considered if the focus was solely on the content to be presented. Since it's an announcement *of* participation, RNS is chosen as the general corporate communication category.
2021-01-06 English
GENFIT: Renegotiation of the OCEANEs Convertible Bond Terms: Availability of Prospectus Relating to the Admission of New Shares Following Conversion of the OCEANEs
Capital/Financing Update Classification · 95% confidence The document is an announcement dated December 22, 2020, regarding the filing and approval of a Prospectus by the French Autorité des marchés financiers (AMF) concerning the renegotiation of convertible bonds (OCEANEs). The core of the document details a proposed Transaction involving a partial buyback and adjustments to the bond terms, which is subject to shareholder and bondholder approval meetings. Crucially, the document explicitly states: "This press release is not an advertisement and does not constitute a prospectus for the purpose of the Prospectus Regulation." It then details where the actual Prospectus (which includes an amendment to the Universal Registration Document and a securities note) can be obtained. Since this is an announcement about the publication/availability of a formal offering document (the Prospectus) and related expert reports, and not the comprehensive annual report (10-K) or a standard quarterly report (IR), it fits best under the category for announcements regarding the publication of reports or regulatory filings related to capital structure changes. Given the focus on the Prospectus availability and the underlying capital transaction (OCEANEs conversion/adjustment), it relates closely to financing activities (CAP). However, the primary action described is the announcement of the availability of the Prospectus itself, which is a specific type of regulatory disclosure. Since the document is an announcement about the availability of a Prospectus related to capital restructuring (OCEANEs), it is a strong candidate for Capital/Financing Update (CAP) or Report Publication Announcement (RPA). Because the document is substantial (over 7,000 characters) and details the complex terms of the financing/capital change (Partial Buyback, OCEANEs Adjustments), classifying it as a Capital/Financing Update (CAP) is more specific than the general RPA, as the financing terms are the central subject matter, even though the Prospectus availability is mentioned. The document details the terms of the financing/capital structure change (OCEANEs renegotiation and share issuance implications).
2020-12-22 English
GENFIT : Renégociation des termes des OCEANEs : mise à disposition d’un prospectus relatif à l’admission d’actions nouvelles en cas de conversion des OCEANEs
Report Publication Announcement Classification · 98% confidence The document is a press release dated December 22, 2020, announcing that GENFIT has filed an amendment to its universal registration document and that the AMF (Autorité des marchés financiers) has approved a Prospectus related to the admission of new shares resulting from the potential conversion of OCEANEs (convertible bonds). The core of the document is the announcement of the availability of this Prospectus and the details of the proposed transaction (Partial Buyback and Adjustment of OCEANEs terms), which requires shareholder and bondholder votes. Although it discusses a Prospectus, the document itself is a press release announcing regulatory actions and upcoming votes. It explicitly states: "Ce communiqué n'est pas une communication à caractère promotionnelle et ne constitue pas un prospectus au sens du Règlement Prospectus." This structure—announcing the publication of a key regulatory document (Prospectus) and providing key details—is characteristic of a Report Publication Announcement (RPA). It is not the full Annual Report (10-K), an Interim Report (IR), or a simple Earnings Release (ER). Since it is announcing the publication of a formal document (Prospectus/Registration Document Amendment), RPA is the most fitting category, as it signals the release of required information.
2020-12-22 French

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.